Kisqali 400 MG daily dose UU 42S
Ended Awarded Last action
- Contract number
- SPE2DR26FQV4X
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $97,010
Award facts
- Contract value 100% obligated
- $97,009.63 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $97,009.63 to AmerisourceBergen Drug Corp for the supply of Kisqali 400 mg daily dose in quantities of 42 units. This firm fixed-price, non-set-aside contract was awarded on January 28, 2026, with an ultimate completion date of February 19, 2026. The pharmaceutical product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, a $999.99 billion vehicle valued through December 31, 2031, which serves as the primary contracting mechanism for delivering comprehensive pharmaceutical and medical supply support to military healthcare systems globally.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, is a critical vendor for federal medical procurement and demonstrates substantial capability in fulfilling Defense Logistics Agency requirements across multiple therapeutic domains. As a subsidiary of Cencora, Inc., the company supplies brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities to support military and veteran healthcare systems. The competitive award reflects the contractor's ability to meet federal procurement standards through open competition, consistent with the DLA's approach to pharmaceutical procurement for Department of Defense medical supply chains.
Quick answers
Who was awarded contract SPE2DR26FQV4X?
SPE2DR26FQV4X was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 28, 2026.
How much is contract SPE2DR26FQV4X worth?
The government has obligated $97,010 on SPE2DR26FQV4X.
Is contract SPE2DR26FQV4X an order under another contract?
Yes. SPE2DR26FQV4X is a delivery order under SPE2DR25D1022, an indefinite delivery contract.
Was contract SPE2DR26FQV4X competed?
The extent of competition for SPE2DR26FQV4X was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award